Survival advantage for irinotecan versus best supportive care as second-line chemotherapy in gastric cancer – A randomised phase III study of the Arbeitsgemeinschaft Internistische Onkologie (AIO)Peter Thuss‐Patience, Peter Reichardt, Yasemin Doğan et al.|European Journal of Cancer|2011Cited by 615
Perioperative chemotherapy with docetaxel, cisplatin and capecitabine (DCX) in gastro-oesophageal adenocarcinoma: a phase II study of the Arbeitsgemeinschaft Internistische Onkologie (AIO)Peter Thuss‐Patience, B. Gahn, Ralf‐Dieter Hofheinz et al.|Annals of Oncology|2012Cited by 70
Docetaxel and capecitabine for advanced gastric cancer: investigating dose-dependent efficacy in two patient cohortsPeter Thuss‐Patience, Peter Reichardt, Christian Grieser et al.|British Journal of Cancer|2011Cited by 23